 |
bevacizumab |
|---|---|
| Trade Name | Avastin |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2004-10-20 00:00:00 |
| Sponsor | Genentech, Inc.;1 DNA Way, MS #242;South San Francisco, California, 94080 |
| |
bevacizumab |
|---|---|
| Trade Name | Avastin |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2004-10-20 00:00:00 |
| Sponsor | Genentech, Inc.;1 DNA Way, MS #242;South San Francisco, California, 94080 |